Pierre Rizkallah - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pierre Rizkallah

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Frontiers in Immunology|April 2, 2019

Peptide Super-Agonist Enhances T-Cell Responses to MelanomaSarah A E Galloway, Garry Dolton, Meriem Attaf, et al.

The Journal of Experimental Medicine|April 20, 2005

Structural and kinetic basis for heightened immunogenicity of T cell vaccinesJi-Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, et al.

Blood|December 21, 2012

Peptide length determines the outcome of TCR/peptide-MHCI engagementJulia Ekeruche-Makinde, John J Miles, Hugo A van den Berg, et al.

Cell|July 25, 2023

Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapyGarry Dolton, Cristina Rius, Aaron Wall, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Frontiers in Immunology|April 2, 2019

Peptide Super-Agonist Enhances T-Cell Responses to MelanomaSarah A E Galloway, Garry Dolton, Meriem Attaf, et al.

The Journal of Experimental Medicine|April 20, 2005

Structural and kinetic basis for heightened immunogenicity of T cell vaccinesJi-Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, et al.

Blood|December 21, 2012

Peptide length determines the outcome of TCR/peptide-MHCI engagementJulia Ekeruche-Makinde, John J Miles, Hugo A van den Berg, et al.

Cell|July 25, 2023

Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapyGarry Dolton, Cristina Rius, Aaron Wall, et al.

Pageof 3